Correlation of influenza virus excess mortality with antigenic variation: Application to rapid estimation of influenza mortality burden

PLoS Computational Biology

Volumn 6, Issue 8, 2010, Pages

  Wu, Aiping ^a   Peng, Yousong ^a,b   Du, Xiangjun ^a,b   Shu, Yuelong ^c   Jiang, Taijiao ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; COST EFFECTIVENESS;

'CURRENT; ANTIGENIC VARIATION; ANTIGENICITY; ANTIGENICS; HOST-VIRUS INTERACTIONS; HUMAN INFLUENZA VIRUS; INFLUENZA VIRUS; INTERACTION MODELING; POSITIVE CORRELATIONS; RAPID ESTIMATION;

VIRUSES;

HEMAGGLUTININ;

AMINO ACID SEQUENCE; ANTIGENIC VARIATION; ANTIGENICITY; ARTICLE; HUMAN; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MORTALITY; NONHUMAN; SEASONAL INFLUENZA; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS STRAIN;

HUMAN INFLUENZA VIRUS; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 78049447821     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1000882     Document Type: Article

References (24)

1. WHO (2010) http://www.who.int/mediacentre/factsheets/fs211/en/.
2. Nelson MI, Holmes EC (2007) The evolution of epidemic influenza. Nat Rev Genet 8: 196-205.
3. Beare AS (1982) Basic and applied influenza research. Boca Raton, Fla.: CRC Press. pp 11-50.
4. Johnson NP, Mueller J (2002) Updating the accounts: global mortality of the 1918-1920 ''Spanish'' influenza pandemic. Bull Hist Med 76: 105-115.
5. Garske T, Legrand J, Donnelly CA, Ward H, Cauchemez S, et al. (2009) Assessing the severity of the novel influenza A/H1N1 pandemic. Br Med J 339: b2840.
6. Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ, et al. (2005) Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 165: 265-272.
7. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, et al. (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289: 179-186.
8. Couch RB, Kasel JA (1983) Immunity to influenza in man. Annu Rev Microbiol 37: 529-549.
9. Upphoff H, Geis S, Gruber A, Hauri A (2009) What will the next influenza season bring about: seasonal influenza or the new A(H1N1)v? An analysis of German influenza surveillance data. Euro Surveill 14(32): pii =19303.
10. R Development Core Team. The R project for statistical computingMdison, WI: University of Wisconsin, 2003-2004. http://www.r-project.org/.
11. Julian JFaraway (2006) Extending the linear model with R:Generalized linear, mixed effects and nonparametric regression models. Boca Raton Lodon New York: CRC press. pp 243-244.
12. Centers for Disease Control and Prevention (2009) Flu activity and surveillance. http://www.cdc.gov/flu/weekly/fluactivity.htm.
13. Skibbe D, Zhou EM, Janke BH (2004) Comparison of a commercial enzymelinked immunosorbent assay with hemagglutination inhibition assay for serodiagnosis of swine influenza virus (H1N1) infection. J Vet Diagn Invest 16: 86-89.
14. Liao YC, Lee MS, Ko CY, Hsiung CA (2008) Bioinformatics models for predicting antigenic variants of influenza A/H3N2 virus. Bioinformatics 24: 505-512.
15. Gupta V, Earl DJ, Deem MW (2006) Quantifying influenza vaccine efficacy and antigenic distance. Vaccine 24: 3881-3888.
16. Zambon MC (2001) The pathogenesis of influenza in humans. Rev Med Virol 11: 227-241.
17. Leigh MW, Connor RJ, Kelm S, Baum LG, Paulson JC (1995) Receptor specificity of influenza virus influences severity of illness in ferrets. Vaccine 13: 1468-1473.
18. Fleming DM, Elliot AJ (2008) Lessons from 40 years' surveillance of influenza in England and Wales. Epidemiol Infect 136: 866-875.
19. Lowen AC, Mubareka S, Steel J, Palese P (2007) Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog 3: 1470-1476.
20. Nichol KL (2003) The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 21: 1769-1775.
21. Park AW, Daly JM, Lewis NS, Smith DJ, Wood JLN, et al. (2009) Quantifying the Impact of Immune Escape on Transmission Dynamics of Influenza. Science 326: 726-728.
22. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, et al. (2009) Cross- Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus. N Engl J Med 361: 1-8.
23. Ndifon W, Dushoff J, Levin SA (2009) On the use of hemagglutinationinhibition for influenza surveillance: surveillance data are predictive of influenza vaccine effectiveness. Vaccine 27: 2447-2452.
24. Archetti I, Horsfall FL, Jr. (1950) Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum. J Exp Med 92: 441-462.